Defining the Benefits of Antibiotic Resistance in Commensals and the Scope for Resistance Optimization

Authors:

Abstract
Antibiotic resistance is commonly viewed as universally costly, regardless of which bacterial cells express resistance. Here, we derive an opposing logic, where resistance in commensal bacteria can lead to reductions in pathogen density and improved outcomes on both the patient and public health scales.
Funding Information
  • Cystic Fibrosis Foundation (BROWN19P0, BROWN21P0)
  • Cystic Fibrosis Foundation (WOLLEI19F0)
  • DOD | National Defense Science and Engineering Graduate
  • DOD | US Army | RDECOM | Army Research Office (W911NF-19-1-0384)
  • HHS | Centers for Disease Control and Prevention (75D30120C-09782)
  • HHS | National Institutes of Health (R01DE020100)

This publication has 60 references indexed in Scilit: